Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial

Background In event‐driven clinical trials, study termination is based on accrual of a target number of primary efficacy events. For noninferiority trials in which superiority is conditionally examined, the ideal cohort in which to track event accrual is unclear. We used data from the ROCKET AF (Riv...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Anthony P. Carnicelli, Anne S. Hellkamp, Kenneth W. Mahaffey, Daniel E. Singer, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A. A. Fox, Robert M. Califf, Manesh R. Patel
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2021-10-01
Serie:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Soggetti:	anticoagulation atrial fibrillation clinical trial embolic stroke research methodology warfarin
Accesso online:	https://www.ahajournals.org/doi/10.1161/JAHA.121.022485
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!